Navigation Links
Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
Date:5/1/2012

. Partners and collaborators include the University of Pennsylvania, Merck, ChronTech, National Cancer Institute, U.S. Military HIV Research Program, NIH, HIV Vaccines Trial Network, University of Southampton, US Dept. of Homeland Security and PATH Malaria Vaccine Initiative. More information is available at www.inovio.com.

This press release contains certain forward-looking statements relating to our business, including our plans to develop electroporation-based drug and gene delivery technologies and synthetic vaccines and our capital resources. Actual events or results may differ from the expectations set forth herein as a result of a number of factors, including uncertainties inherent in pre-clinical studies, clinical trials and product development programs (including, but not limited to, the fact that pre-clinical and clinical results referenced in this release may not be indicative of results achievable in other trials or for other indications, that the studies or trials may not be successful or achieve the results desired, that pre-clinical studies and clinical trials may not commence or be completed in the time periods anticipated, that results from one study may not necessarily be reflected or supported by the results of other similar studies and that results from an animal study may not be indicative of results achievable in human studies), the availability of funding to support continuing research and studies in an effort to prove safety and efficacy of electroporation technology as a delivery mechanism or develop viable synthetic vaccines, the adequacy of our capital resources, the availability or potential availability of alternative therapies or treatments for the conditions targeted by the company or its collaborators, including alternatives that may be more efficacious or cost-effective than any therapy or treatment that the company and its collaborators hope to develop, evaluation of potential opportun
'/>"/>

SOURCE Inovio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Inovio Receives U.S. Patent for SynCon® H1N1 Influenza Universal Vaccine
2. Inovio Pharmaceuticals to Present at Biotech Showcase Investor Conference
3. Inovio Pharmaceuticals to Present at Oppenheimer Investor Conference
4. Inovio Pharmaceuticals Closes $4.0 Million Underwritten Financing
5. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
6. Inovio Pharmaceuticals Cervical Dysplasia And Cancer Treatment Highlighted as One of 10 Promising Therapeutic Vaccines; Phase II Clinical Study Currently Enrolling
7. Inovio Pharmaceuticals and VGX International to Advance Therapeutic Hepatitis C and Hepatitis B Synthetic Vaccines into Clinical Studies
8. Inovio Pharmaceuticals Leadership for Life Sciences Recognized in the Philadelphia Region
9. Inovio Pharmaceuticals Synthetic Vaccine for Cancer Recognized as Most Promising Research at Global Vaccine Congress
10. Inovio Pharmaceuticals Enters Collaboration With U.S. Dept. of Homeland Security to Assess Foot & Mouth Disease Synthetic Vaccines Potential to Help Ensure Nations Food Supply Safety
11. Inovio Pharmaceuticals Completes PENNVAX™-B HIV Vaccine Phase I Study, Demonstrates Best-in-Class T-Cell Immune Responses
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/20/2014)... 2014 /CNW/ - The issue: Mylan Pharmaceuticals ULC Canada, in ... its Mylan-Nitro Spray 0.4 mg/metered dose due to the product ... component. A missing "dip tube" could pose ... patient. This defect may lead patients to believe they are ... access it. Not receiving nitroglycerin could place them at risk ...
(Date:9/19/2014)... , Sept. 19, 2014 Medical ... forging relationships with key opinion leaders (KOLs) who ... competition. Despite the critical nature of the MSL ... challenges, including altering the landscape for creating and ... According to research, the oversight responsibility for the ...
(Date:9/19/2014)... 19, 2014 Harwood Feffer LLP ( www.hfesq.com ... directors of PDL BioPharma, Inc. ("PDL" or the "Company") ... has breached its fiduciary duties to shareholders or violated ... 2014, the Company disclosed: "On September 11, 2014, [PDL] ... Ernst & Young LLP ("EY"), that it was resigning ...
Breaking Medicine Technology:Advisory - Mylan Pharmaceuticals recalling nitroglycerin spray due to defective pump 2Role of Medical Science Liaisons Shifting in Healthcare Industry 2Harwood Feffer LLP Announces Investigation of PDL BioPharma, Inc. 2
... a,division of Ortho-McNeil-Janssen Pharmaceuticals, Inc., announced today,that the ... pediatric,exclusivity for TOPAMAX(R) (topiramate), based on studies submitted ... to investigate the use of TOPAMAX,in pediatric patients ... seizures., In addition to granting pediatric exclusivity, ...
... There are a record 301,new medicines being ... released here today during a briefing that focused ... patients, their families,and society. Nationwide, mental illness affects ... the Pharmaceutical Research and Manufacturers,of America (PhRMA), featured ...
Cached Medicine Technology:FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 2FDA Grants Pediatric Exclusivity for TOPAMAX(R), Extending the Marketing Exclusivity by Six Months 3More Than 300 New Medicines Being Developed for Mental Illnesses 2More Than 300 New Medicines Being Developed for Mental Illnesses 3More Than 300 New Medicines Being Developed for Mental Illnesses 4
(Date:9/20/2014)... Recently, iFitDress.com, a well-known wedding dress manufacturer ... party dresses . In addition, the company has launched a ... the promotion is to benefit all of its big fans. ... store now. , Along with beautiful party dresses, the ... has recently released its new sexy short prom outfits and ...
(Date:9/20/2014)... (PRWEB) September 21, 2014 Recently, UWDress.com, ... has launched a promotion for its newly announced ... most of the company’s special occasion outfits are very ... outfits are provided with big savings (up to 65 ... hard to offer more fashionable special occasion outfits for ...
(Date:9/20/2014)... NV (PRWEB) September 21, 2014 ... Dr. Kenneth Pullman that is helping thousands of people ... diabetes symptoms without shots, pills, or prescriptions has caught ... , “There are currently tens of millions of ... Type 1 and Type 2 diabetes, and unfortunately, big ...
(Date:9/20/2014)... 21, 2014 Weight Destroyer , ... fitness expert Michael Wren that has already helped tens ... reverse health conditions like high blood pressure, high cholesterol, ... Michaels, prompting an investigative review. , “Weight Destroyer ... upside down by showing people what is truly effective ...
(Date:9/20/2014)... 6 Minutes to Skinny , a ... Ballantyne that is showing men and women of all ages ... body fat using simple 6-minute exercises and easy-to-follow lifestyle tips ... investigative review. , “When it comes to losing body ... out for all people,” reports Michaels. “Metabolism plays a big ...
Breaking Medicine News(10 mins):Health News:Beautiful Party Dresses For Autumn Unveiled By iFitDress.com 2Health News:Cheap Evening Cocktail Dresses Recently Introduced At UWDress.com 2Health News:Diabetes Protocol: Review Exposes Kenneth Pullman’s Breakthrough Discovery About Diabetes Management 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 2Health News:Weight Destroyer: Review Exposes Michael Wren’s Guide to Effective Weight Loss and Improved Health 3Health News:6 Minutes to Skinny: Review Exposes Craig Ballantyne’s Method to Jump Starting the Metabolism and Blasting Away Body Fat in Just 6 Minutes Per Day 2
... cancer is expected to be unsuccessful. Statisticians with the US ... in the hunt for common inherited genetic variants that would ... there are a number of problems when doing such a ... that common genes are unlikely to exist nor have ...
... With one of the highest percentages of undernourished children ... states a new World Bank report released Thursday//. ... significant changes to address the current malnutrition crisis," states ... and Action". ,The prevalence of underweight children in ...
... Cancer Institute in Bethesda, Maryland, and Jaakko Kaprio, a genetic ... waste of time and money to search for genes linked ... Medical Journal. They say that there is very little chance ... is being invested. Researchers believe that if they can identify ...
... should practice less invasive surgery for by pass surgery. They ... increase the chances of exposing patients to innumerable infections. Most ... infections. In the traditional method the great saphenous vein is ... This enhances the blood flow to the heart muscle ...
... of the American Society of Nephrology has stated that ... failure//. ,"Our results confirm an accumulating body of ... causative factor in kidney disease," comments Dr. Elisabeth Ejerblad ... study. ,Dr. Ejerblad and colleagues assessed body mass ...
... will help cigarette smokers to quit smoking, wins ... active ingredient in Chantix is varenicline tartrate. The ... better effectiveness shown in preliminary trials compared to ... priority review get approved or rejected within six ...
Cached Medicine News:Health News:Malnutrition Crisis On Rise In India: World Bank 2Health News:Kidney Failure three times pronounced with obesity 2
An entirely new way to brighten and enhance natural eye color....
Disposable-type color lenses for exciting eye color change....
... The world standard in corneal ... like endothelium, descemet's membrane, stroma, Bowman's ... of Corneal Components. Broad Applications in ... pachymetry, post-surgery interface evaluation, endothelial cell ...
... Vasculight SR improves the appearance of photo-aged ... benign brown pigments, telangiectasias, and broken capillaries. ... pulsed light (IPLTM) treats pigmentary sun damage ... combined approach of IPL and the Nd:YAG ...
Medicine Products: